Literature DB >> 36211207

Primary heart involvement in systemic sclerosis, from conventional to innovative targeted therapeutic strategies.

Arianna Ferlito1, Corrado Campochiaro1,2, Alessandro Tomelleri1,2, Lorenzo Dagna1,2, Giacomo De Luca1,2.   

Abstract

Primary heart involvement is frequent in systemic sclerosis, even though often sub-clinical, and includes cardiac abnormalities that are predominantly attributable to systemic sclerosis rather than other causes and/or complications. A timely diagnosis is crucial to promptly start the appropriate therapy and to prevent the potential life-threatening early and late complications. There is little evidence on how to best manage systemic sclerosis-primary heart involvement as no specific treatment recommendations for heart disease are available, and a shared treatment approach is still lacking. The objective of this review is to summarize the state of the art of current literature and the overall management strategies and therapeutic approaches for systemic sclerosis-primary heart involvement. Novel insights into pathogenic mechanisms of systemic sclerosis-primary heart involvement are presented to facilitate the comprehension of therapeutic targets and novel treatment strategies.
© The Author(s) 2022.

Entities:  

Keywords:  Systemic sclerosis; fibrosis; inflammation; primary heart involvement; therapy

Year:  2022        PMID: 36211207      PMCID: PMC9537702          DOI: 10.1177/23971983221083772

Source DB:  PubMed          Journal:  J Scleroderma Relat Disord        ISSN: 2397-1983


  83 in total

Review 1.  2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).

Authors:  Silvia G Priori; Carina Blomström-Lundqvist; Andrea Mazzanti; Nico Blom; Martin Borggrefe; John Camm; Perry Mark Elliott; Donna Fitzsimons; Robert Hatala; Gerhard Hindricks; Paulus Kirchhof; Keld Kjeldsen; Karl-Heinz Kuck; Antonio Hernandez-Madrid; Nikolaos Nikolaou; Tone M Norekvål; Christian Spaulding; Dirk J Van Veldhuisen
Journal:  Europace       Date:  2015-08-29       Impact factor: 5.214

2.  Severe myositis and myocarditis in progressive systemic sclerosis.

Authors:  S Carette; J Turcotte; G Mathon
Journal:  J Rheumatol       Date:  1985-10       Impact factor: 4.666

3.  Adverse events during the Scleroderma Lung Study.

Authors:  Daniel E Furst; Chi-Hong Tseng; Philip J Clements; Charlie Strange; Donald P Tashkin; Michael D Roth; Dinesh Khanna; Ning Li; Robert Elashoff; Dean E Schraufnagel
Journal:  Am J Med       Date:  2011-05       Impact factor: 4.965

4.  Nonclassical resident macrophages are important determinants in the development of myocardial fibrosis.

Authors:  Alec Falkenham; Roberto de Antueno; Nicole Rosin; Devin Betsch; Timothy D G Lee; Roy Duncan; Jean-Francois Légaré
Journal:  Am J Pathol       Date:  2015-04       Impact factor: 4.307

Review 5.  Systemic sclerosis: a prototypic multisystem fibrotic disorder.

Authors:  John Varga; David Abraham
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

6.  Non-invasive evaluation of long-term cardiac effects of captopril in systemic sclerosis.

Authors:  E Kazzam; K Caidahl; R Hllgren; R Gustafsson; A Waldenström
Journal:  J Intern Med       Date:  1991-09       Impact factor: 8.989

7.  Speckle tracking echocardiography in systemic sclerosis: A useful method for detection of myocardial involvement.

Authors:  I Zairi; K Mzoughi; Z Jnifene; S Kamoun; M Jabeur; F Ben Moussa; S Kraiem
Journal:  Ann Cardiol Angeiol (Paris)       Date:  2018-10-02

Review 8.  The Macrophage in Cardiac Homeostasis and Disease: JACC Macrophage in CVD Series (Part 4).

Authors:  Kory J Lavine; Alexander R Pinto; Slava Epelman; Benjamin J Kopecky; Xavier Clemente-Casares; James Godwin; Nadia Rosenthal; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2018-10-30       Impact factor: 24.094

9.  Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy.

Authors:  Karin A L Mueller; Iris I Mueller; David Eppler; Christine S Zuern; Peter Seizer; Ulrich Kramer; Ina Koetter; Martin Roecken; Reinhard Kandolf; Meinrad Gawaz; Tobias Geisler; Joerg C Henes; Karin Klingel
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

10.  Echocardiographic follow-up of patients with systemic sclerosis by 2D speckle tracking echocardiography of the left ventricle.

Authors:  Sebastian Spethmann; Karl Rieper; Gabriela Riemekasten; Adrian C Borges; Sebastian Schattke; Gerd-Ruediger Burmester; Bernd Hewing; Gert Baumann; Henryk Dreger; Fabian Knebel
Journal:  Cardiovasc Ultrasound       Date:  2014-03-29       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.